Immune-Checkpoint Inhibitors in B-Cell Lymphoma

Immune-Checkpoint Inhibitors in B-Cell Lymphoma

For years, immunotherapy has been considered a viable and attractive treatment option for patients with cancer. Among the immunotherapy arsenal, the targeting of intratumoral immune cells by immune-checkpoint inhibitory agents has recently revolutionised the treatment of several subtypes of tumours....

Full description

Bibliographic Details
Main Authors:	Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gaël Roué
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Cancers
Subjects:	immune checkpoint lymphoid neoplasms programmed death 1 cytotoxic T-lymphocyte antigen 4 monoclonal antibodies combination therapies
Online Access:	https://www.mdpi.com/2072-6694/13/2/214

Similar Items

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
by: Shigehisa Kitano, et al.
Published: (2018-07-01)

Immune Checkpoint Inhibitors in Melanoma: Review and Update
by: Eugénia Matos Pires, et al.
Published: (2018-10-01)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
by: Thilo Gambichler, et al.
Published: (2020-11-01)

Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
by: Ioana Plesca, et al.
Published: (2020-03-01)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019-11-01)

Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
by: Katsiaryna Marhelava, et al.
Published: (2019-11-01)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
by: Wenxiang Zhang, et al.
Published: (2021-09-01)

Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
by: Li Wang, et al.
Published: (2021-09-01)

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
by: Grywalska E, et al.
Published: (2018-10-01)

Cardiac Complications in Immune Checkpoint Inhibition Therapy
by: Kazuko Tajiri, et al.
Published: (2019-01-01)

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
by: Jennifer Kleponis, et al.
Published: (2015-09-01)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
by: Shima Makaremi, et al.
Published: (2021-08-01)

Immunological and translational aspects of NK cell-based anti-tumor immunotherapies
by: Maxim Shevtsov, et al.
Published: (2016-11-01)

Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
by: Zhu Y, et al.
Published: (2018-08-01)

Immune-mediated adverse rheumatic reactions following administration of immune checkpoint inhibitors
by: I. V. Menshikova, et al.
Published: (2020-09-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
by: Nicholas Gravbrot, et al.
Published: (2019-10-01)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
by: Anja Wessely, et al.
Published: (2020-01-01)

Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
by: Ewelina Grywalska, et al.
Published: (2019-09-01)

A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1 Antibody-Safety and Effectiveness of Pirfenidone
by: Haiming YU, et al.
Published: (2021-07-01)

Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
by: Evelyn Sirait-Fischer, et al.
Published: (2020-09-01)

Cancer immunotherapy beyond immune checkpoint inhibitors
by: Julian A. Marin-Acevedo, et al.
Published: (2018-01-01)

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
by: Antje Tunger, et al.
Published: (2018-03-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Risk of Gastrointestinal Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Systematic Review and Meta-Analysis
by: Wenhan Yang, et al.
Published: (2020-03-01)

Elucidating the Functional Roles of Helper and Cytotoxic T Cells in the Cell-Mediated Immune Responses of Olive Flounder (<i>Paralichthys olivaceus</i>)
by: Jae Wook Jung, et al.
Published: (2021-01-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

Studies on the functional heterogeneity of rat T cells using monoclonal antibodies
by: Spickett, Gavin
Published: (1983)

Dual checkpoint inhibitor induced autoimmune encephalitis
by: Elkayam Natalie, et al.
Published: (2019-01-01)

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
by: Mirjam Fässler, et al.
Published: (2019-02-01)

Gastrointestinal disorders as immune-related adverse events
by: Daniele Balducci, et al.
Published: (2021-04-01)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
by: Teresa Poggio, et al.
Published: (2018-09-01)

Monoclonal Antibodies in Cancer Therapy
by: David Zahavi, et al.
Published: (2020-07-01)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
by: Jared M. Newton, et al.
Published: (2019-08-01)

Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
by: Regzedmaa O, et al.
Published: (2019-06-01)

New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
by: Babita Agrawal
Published: (2019-08-01)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020-12-01)

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas
by: Massimo Fantini, et al.
Published: (2018-01-01)

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
by: Angela Rita Elia, et al.
Published: (2018-07-01)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
by: Hamzah Abu-Sbeih, et al.
Published: (2019-02-01)

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
by: Frank Stenner, et al.
Published: (2018-06-01)